Regeneron (REGN) Stock Price

$700.3 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    8

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Regeneron, AI stock picks, stock alerts and much more.

Sign up

REGN AI Stock Analysis

AI stock analysis for REGN is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Regeneron (REGN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Regeneron (REGN) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Regeneron (REGN), currently trading at $700.3, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About REGN

LSE

  • Regeneron Pharmaceuticals, Inc.

  • Symbol

    REGN

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    75.3B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
INO Inovio Pharmaceuticals
INO		 $2.24
0.9%
2
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6

News

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN
February 22, 2025. accessnewswire.com
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – REGN

Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – REGN
February 21, 2025. globenewswire.com
Regeneron Pharmaceuticals (REGN) Faces Mounting Pressure on Sales, Legal Fronts – Hagens Berman

Regeneron Pharmaceuticals (REGN) Faces Mounting Pressure on Sales, Legal Fronts – Hagens Berman
February 21, 2025. globenewswire.com
Shareholders that lost money on Regeneron Pharmaceuticals, Inc. (REGN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Shareholders that lost money on Regeneron Pharmaceuticals, Inc. (REGN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
February 21, 2025. accessnewswire.com

REGN Alternative Data

Web Traffic

Regeneron receives an estimated 345173 monthly visitors to regeneron.com.

  • Web Traffic

    345173

  • Change from Previous Month

    33.4%

  • 3 Month Change

    4%

  • YoY Change

    4%

News Mentions

Regeneron was mentioned 2 times in the news yesterday.

  • News Mentions

    2

  • Daily Change

    100%

  • 1 Month Change

    33.3%

  • 3 Month Change

    100%

Reddit Mentions

Regeneron has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Twitter Followers

Regeneron has 33,005 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.

  • Twitter Followers

    33005

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Facebook Engagement

Regeneron has engaged 292 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    292

  • Daily Change

    20.7%

  • 1 Month Change

    68.8%

  • 3 Month Change

    57.8%

  • YoY Change

    57.8%

Instagram Followers

Regeneron has 13,960 Instagram Followers on its main Instagram account, up by 1.3% over the last month.

  • Instagram Followers

    13960

  • Daily Change

    0%

  • 1 Month Change

    1.3%

  • 3 Month Change

    3.4%

  • YoY Change

    3.4%

LinkedIn Followers

518,635 are following Regeneron on LinkedIn, up by 1.7% over the last month.

  • LinkedIn Followers

    518635

  • Daily Change

    0.1%

  • 1 Month Change

    1.7%

  • 3 Month Change

    3.8%

Job Postings

Regeneron has an estimated 318 open job postings, which is down -8.4% over the last month.

  • Job Postings

    318

  • Daily Change

    1.6%

  • 1 Month Change

    8.4%

  • 3 Month Change

    25.9%

  • YoY Change

    25.9%

LinkedIn Employees

According to LinkedIn, Regeneron has 15,724 employees, up by 0.5% over the last month.

  • LinkedIn Employees

    15724

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    1.6%

  • YoY Change

    1.6%

Business Outlook

  • Business Outlook

    81

  • Change from Previous Month

    1.2%

  • 3 Month Change

    0%

  • YoY Change

    0%

REGN Financials

REGN Key Metrics

  • Total Revenue

    $3.7B

  • Net Income

    $1.3B

  • Earnings per Share

    $12.4

  • Free cash flow

    $1.1B

  • EBITDA

    $1.2B

  • EBITDA Ratio

    0.31701

  • Total Assets

    $37.4B

REGN 2-year Revenue & Income
REGN 2-year Free Cash Flow

REGN Technicals

REGN SMA
REGN RSI

FAQ

What's the current price of Regeneron (REGN) Stock?
The price of an Regeneron (REGN) share is $700.3.

What's the market cap of Regeneron?
The current market cap of Regeneron is 75.3B.

Should I buy or sell REGN?
Multiple alternative data signals suggest that Regeneron stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Regeneron a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Regeneron stock. The bullish indicators suggest that Regeneron's growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Regeneron (REGN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Regeneron stock, given the bullish outlook.

What are some stocks similar to Regeneron (REGN) that investors often compare it to?
Regeneron (REGN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Regeneron's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Regeneron's stock price to be around $749.1 in 2026. Starting from the current price of $700.3, this represents a 7% change in price, indicating a bullish outlook for the stock.

How to buy Regeneron (REGN) Stock?
Regeneron stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Regeneron shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.